Full Text View
Tabular View
No Study Results Posted
Related Studies
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
This study has been completed.
Study NCT00124683   Information provided by National Institute on Drug Abuse (NIDA)
First Received: July 26, 2005   Last Updated: August 1, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tobacco Use Cessation
Tobacco Use Disorder
Schizophrenia
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Substance-Related Disorders
Interventions listed in this trial
Bupropion
nicotine transdermal patch
Additional drug interventions recognized in this trial
Nicotine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Agonists
Dopamine Agents
Dopamine Uptake Inhibitors
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services